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Abstract  
Escherichia coli sequence type 131 (ST131) have emerged as a pandemic lineage of 
important multidrug resistant pathogens worldwide. Despite many studies examining 
the epidemiology of ST131, only a few studies to date have investigated the capacity 
of ST131 strains to form biofilms. Some of these studies have reported contrasting 
findings, with no specific ST131 biofilm-promoting factors identified. Here we 
examined a diverse collection of ST131 isolates for in vitro biofilm formation in 
different media and assay conditions, including urine from healthy adult women.  We 
found significant differences among strains and assay conditions, which offers an 
explanation for the contrasting findings reported by previous studies using a single 
condition. Importantly, we showed that expression of type 1 fimbriae is a critical 
determinant for biofilm formation by ST131 strains and that inhibition of the FimH 
adhesin significantly reduces biofilm formation. We also offer direct genetic evidence 
for the contribution of type 1 fimbriae in biofilm formation by the reference ST131 
strain EC958, a representative of the clinically dominant H30-Rx ST131 subgroup. 
This is the first study of ST131 biofilm formation in biologically relevant conditions 
and paves the way for the application of FimH inhibitors in treating drug resistant 
ST131 biofilm infections.  
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Escherichia coli sequence type 131 (E. coli ST131) is a major cause of multidrug 
resistant extraintestinal infections in hospitals and the community and its recent 
emergence and global dissemination have been widely documented (Banerjee and 
Johnson 2014; Petty et al. 2014; Price et al. 2013). A large number of studies to date 
have investigated the global epidemiology of ST131, resulting in an increasingly 
detailed molecular understanding of diversity within this lineage, with particular focus 
on multidrug resistance and virulence - a combination of traits that defines E. coli 
ST131 (Olesen et al. 2014; Petty et al. 2014; Totsika et al. 2011).  
 
Comparatively few studies, however, have investigated the biofilm forming properties 
of ST131, despite biofilm formation on biotic and abiotic surfaces being a key 
virulence trait in extraintestinal pathogenic E. coli (ExPEC) strains from other STs 
[reviewed in (Jorgensen and Seed 2012; Subashchandrabose and Mobley 2015)]. 
Additionally, in studies where ST131 biofilm formation has been examined findings 
are highly contrasting. For example, one of the first reports on the global emergence 
of ST131 showed that two representative strains can form biofilms on glass surfaces 
in vitro (Clermont et al. 2008). A later study characterized a larger collection of 
ST131 isolates of diverse origin and virulence gene content (n=20), reporting in 
contrast very low levels of adhesion to polystyrene surfaces and biofilm formation, 
and concluding that ST131 strains may utilise other mechanisms to drive persistence 
(Novais et al. 2012). Hussain and colleagues, on the other hand, reported moderate to 
high biofilm levels in two Indian collections of clinical ST131 isolates published in 
2012 and 2014 (n=15 and 43, respectively) (Hussain et al. 2012; Hussain et al. 2014).  
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Studies where prevalence of biofilm production was reported instead of actual biofilm 
levels are also contrasting. Kudinha et al., 2013 reported higher prevalence of biofilm 
production by Australian ST131 versus non-ST131 isolates from women with cystitis 
(86% vs. 53%) and pyelonephritis (100% vs. 60%) in a large E. coli isolate collection 
studied (n=953, 144 of which were ST131) (Kudinha et al. 2013b). In contrast, 
Olesen and colleagues reported an overall low prevalence of biofilm formation (15%) 
among a geographically and temporally diverse collection of ST131 isolates of similar 
size (n=128) (Olesen et al. 2014) and no differences in biofilm production between 
ST131 and non-ST131 isolates (Olesen et al. 2013). A temporally decreasing trend in 
ST131 biofilm production was also reported by these authors (Olesen et al. 2014) and 
was mainly attributed to the recent expansion of H30 strains within the ST131 lineage 
(which were reported as low biofilm producers). This observation remains to be 
confirmed by other ST131 isolate collections covering a similar time-span.  
 
The large discrepancy in ST131 biofilm formation reported by these studies is most 
likely due to differences in biofilm methodology and bacterial culture conditions as 
well as data cut-offs and definitions used in prevalence studies. In addition, potential 
differences in the clonal diversity within each ST131 collection could also account for 
the observed differences. Therefore, there is a need for more studies investigating the 
biofilm forming capacity of diverse ST131 strains and the molecular mechanisms that 
promote biofilm formation.  
 
We have previously characterised a collection of 75 clinical ST131 isolates from 
cases of urinary tract infection (UTI) presenting in the UK and Australia for various 
genotypic and phenotypic virulence traits (Totsika et al. 2011). Here we examined the 
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ability of these strains to form biofilms in multiple in vitro conditions, including 
human urine from healthy adult women. We also demonstrated a critical role for type 
1 fimbriae - a key adherence factor with a distinct regulation pattern in the majority of 
ST131 strains (Totsika et al. 2011) - in mediating high-level biofilm formation in 
ST131 strains.  
 
Biofilm formation assays were performed in round-bottom 96-well polystyrene 
(Iwaki, Japan) plate assays, as previously described (Ulett et al. 2007). ST131 strains 
were grown statically in Lysogeny Broth (LB) pH 7 at 37
o
C for two consecutive days 
(subcultured from the air-liquid interface after the first 24 hours) and 2.5 μl of cell 
suspension (OD600 nm 1.0) was used to inoculate each well in triplicate. Biofilm plates 
were incubated statically at 37
o
C in LB (Ulett et al. 2007) or in pooled human urine 
(Watts et al. 2012) for 24 and 48 hours, respectively. Median biofilm levels observed 
in LB were higher compared to urine (1.282 vs. 0.5862, Mann-Whitney U 1346, P< 
0.0001), but the spread observed was similar in both conditions (Fig 1A). As an 
exploratory analysis we further tested a representative subset of 22 isolates in defined 
rich (RPMI 1640 pH 7.4, Life Technologies) or minimal media (modified M9 pH 7 
(Wells et al. 2005) with the addition of 0.2% glucose, 0.3% casamino acids, 0.02% 
thiamine-HCl and 0.2% sodium succinate (Watts et al. 2012)), alone or supplemented 
with 20 μM FeCl2.4H2O. A univariate linear regression was fitted to the biofilm data 
using R (R-Core-Team 2014) (including post-processing using the package “lsmean” 
(Lenth and Hervé 2015)), with strain, media and culture condition fitted as the 
explanatory variables. All three variables were statistically significant at a 5% 
significance level. Adjusting for strain effect, biofilm formation levels were 
significantly different in the various media (Fig 1B).  In particular, iron 
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supplementation of defined media resulted in higher biofilm levels, similar to those 
formed in LB, while biofilm formation in urine and non-supplemented defined media 
were significantly lower. A similar trend for biofilm formation in LB versus human 
urine was recently reported in a collection of 58 epidemiologically unrelated 
extended-spectrum beta-lactamase (ESBL)-producing E. coli isolates from pediatric 
infections (Morgand et al. 2014). Moreover, iron uptake has been previously shown to 
be critical for biofilm formation by E. coli while bacterial survival in biofilms can be 
significantly attenuated by the addition of antagonist molecules, such as other divalent 
metal ions (Hancock et al. 2010). 
 
These results demonstrate that clinical ST131 isolates can display significant 
differences in biofilm formation depending on the culture condition tested, which 
supports previous findings with other clinical E. coli pathogens (Naves et al. 2008; 
Reisner et al. 2006). Importantly, our findings offer a likely explanation for the large 
discrepancies reported in the currently small ST131 biofilm literature and highlight 
the importance of assessing more than one in vitro condition when drawing 
conclusions on the biofilm forming capacity of this diverse yet highly successful E. 
coli lineage.  
 
Genetic diversity in the accessory genome of ST131 strains has been documented 
(Novais et al. 2012; Olesen et al. 2014; Petty et al. 2014; Price et al. 2013) and could 
also explain the differences in biofilm formation observed in heterogeneous 
environmental conditions. Expression of factors shown to promote biofilm formation 
in other reference pathogenic E. coli strains has not been extensively studied in 
ST131, with the exception of type 1 fimbriae, curli and cellulose (Kudinha et al. 
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2013a; Totsika et al. 2011), and no single factor to date has been directly shown to 
contribute to biofilm formation by ST131 strains. We have previously shown that 
expression of type 1 fimbriae was variable within the ST131 isolates in our collection 
due to the high prevalence of an insertion sequence in the fimB recombinase gene 
(Totsika et al. 2011). The high prevalence of this insertion was later confirmed in 
several other diverse ST131 collections and strongly associated with the H30 ST131 
subgroup (Blanco et al. 2013; Paul et al. 2013; Petty et al. 2014).  
 
We hypothesised that variable type 1 fimbriae expression among ST131 strains will 
affect their biofilm formation in vitro. To test this tenet, we grouped our ST131 
strains based on their expression of type 1 fimbriae as determined by yeast cell 
agglutination, to type 1-positive (n=57) or type 1-negative (n=14) strains and biofilm 
levels formed in LB and urine were compared (Fig 1C). In both conditions, strains 
expressing type 1 fimbriae formed significantly stronger biofilms compared to type 1-
negative strains (LB: median 1.424 vs. 0.419, Mann-Whitney U 74, P< 0.0001 and 
Urine: 0.6286 vs. 0.3457, Mann Whitney U 48.5, P<0.0001).  
 
To further establish the contribution of type 1 fimbriae in biofilm formation in the 
type 1-positive group, a random subset of type 1 expressing strains (n=20) was tested 
for biofilm formation in the presence of a potent FimH inhibitor (methyl-α-D-
mannopyranoside (αMM)) (Aronson et al. 1979; Bouckaert et al. 2006). Addition of 
1% αMM in human urine significantly reduced the biofilm levels of type 1-positive 
ST131 strains (Fig 1D; median 0.4236 vs. 0.1915, Mann Whitney U 2, P<0.0001). 
Taken together, these results demonstrate that type 1 fimbriae expression is a critical 
determinant for biofilm formation in E. coli ST131. 
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 In order to directly demonstrate the contribution of type 1 fimbriae in ST131 biofilm 
formation, we employed a type 1 fimbriae null mutant previously constructed in the 
reference ST131 isolate EC958 (EC958fimD (Totsika et al. 2011)). In microtiter plate 
assays the EC958fimD mutant was significantly attenuated for biofilm formation in 
LB (Fig 1E; median 1.778 vs. 0.4616, Mann Whitney U 0, P<0.05). Similar results 
were obtained when mKate-tagged EC958 (wild-type) (Phan et al. 2013) or mKate-
tagged EC958fimD (constructed in this study as described in (Phan et al. 2013; 
Totsika et al. 2011)) were tested in a multi-channel flow chamber system for biofilm 
formation under constant media flow at 37°C (M9-glucose at 4ml/h) (Ulett et al. 
2007). In these assays, wild-type EC958 produced a thick biofilm by 16 hours, while 
the EC958fimD mutant failed to develop a biofilm with only a few sporadic cells 
attaching to the glass surface (Fig 1F) even when left for 40 hours (data not shown). 
 
These findings provide direct evidence for the role of type 1 fimbriae in promoting 
biofilm formation on abiotic surfaces by an ST131 strain. We have recently shown 
that EC958 can form biofilm-like intracellular bacterial communities (IBCs) in the 
murine bladder, indicating that biofilm formation contributes to EC958 pathogenesis 
in vivo (Totsika et al. 2013). Here we show that many ST131 isolates that express 
type 1 fimbriae are able to form in vitro biofilms in a type 1-dependent manner. Our 
study supports the clinical testing of FimH inhibitors in treating ST131 biofilms 
associated with both uncomplicated cystitis and catheter infections. 
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Fig 1. Biofilm formation by E. coli ST131 and the contribution of type 1 
fimbriae. (A) Box-and-whisker plots of biofilm levels in LB and pooled human urine 
for 75 E. coli ST131 clinical isolates. (B) Mean biofilm level (least square means of 
media averaged over stain and culture conditions ± 95% confidence interval) by a 
random subset of 22 ST131 isolates conducted in six different culture media. (C) 
Biofilm formation by ST131 isolates in LB and human urine grouped according to 
type 1 fimbriae expression status in type 1-positive (n=57) or type 1-negative (n=14) 
strains. (D) Biofilm formation by a random subset of 20 Type 1-positive ST131 
isolates in human urine in the absence or presence of 1% methyl-α-D-
mannopyranoside (αMM). (E) Biofilm formation by reference ST131 isolate EC958 
(wild-type, WT) and isogenic type 1 fimbriae null mutant (EC958ΔfimD) in LB. (F) 
Confocal laser scanning fluorescence micrographs of MM9 continuous-flow biofilms 
formed in glass chambers 16 hours after inoculation with mKate-tagged EC958 WT 
or mKate-tagged EC958ΔfimD. Micrographs show representative horizontal sections 
collected within each biofilm. Shown to the right and top of each individual panel are 
vertical sections representing the yz plane and the xz plane, respectively, at the 
positions indicated by the red and green line.  
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